Petros Pharmaceuticals (PTPI) said Tuesday it has priced a public offering of about 40 million shares, or pre-funded warrants, with each share accompanied by a Series A warrant to buy 0.25 share at an exercise price of $0.48 per 0.25 share, and a Series B warrant to buy one share at an exercise price of $0.48 per share.
The combined public offering price of each share with the accompanying Series A warrant and Series B warrant is $0.24, and the combined public offering price of each pre-funded warrant together with the accompanying Series A warrant and Series B warrant is $0.2399, Petros said.
The gross proceeds of the offering are expected to be $9.6 million, the company said.
Net proceeds of the offering, expected to close on or about Wednesday, will be used for working capital and general corporae purposes, the company said.
Price: 0.14, Change: -0.15, Percent Change: -51.19
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
If the download button clicks without skipping, click on the top right menu and select "Open in Browser."